Obesity should not be considered a barrier for a patient who needs a shoulder replacement procedure, researchers argued in a ...

Eli Lilly & Co. and Novo Nordisk A/S plan to start selling their popular obesity shots to employers through a new approach ...

Top scientists from have suggested that GLP-1s could have broader effects than just tackling obesity and diabetes.

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

(Reuters) -The worldwide prevalence of high blood pressure in children and adolescents nearly doubled between 2000 and 2020, ...

This would not be the first time that public-health experts have prematurely celebrated the peak of America’s obesity crisis.

Early baby routines in feeding, sleep, and play link to growth. A tool helps families notice habits that may influence ...

Researchers have identified a neural biomarker of compulsive food cravings, and showed that it is suppressed by the ...

Discover six obesity deals made so far in 2025, with dealmaking activity in the field being largely dominated by big pharma ...

New guidance from the Trump administration directs visa officers to consider common health ailments, including obesity and ...

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness ...

The direct-to-employer (DTE) is an industry first for FDA-approved weight-loss drugs like Novo Nordisk's Wegovy (semaglutide) ...